[ad_1] A U.S. Food and Drug Administration committee voted in favor of Roche Holding AG’s…
Cancer Drugs
-
-
[ad_1] AstraZeneca PLC on Monday said its cancer drug Enhertu has shown clinically meaningful and…
-
STOCK MARKET
Pfizer eyes takeover of biotech Seagen, at value of more than $30 billion
by userby user[ad_1] Pfizer Inc. PFE, -1.30% is in talks to acquire biotech Seagen Inc. SGEN, -0.51%, according to people…
-
STOCK MARKET
One of the greatest cancer drugs ever has suddenly lost its edge. This is why it was vulnerable.
by userby user[ad_1] In November, British-Swedish drug giant AstraZeneca published a simple chart in its quarterly earnings…
-
STOCK MARKET
Drug companies plan to raise prices on vital medicines to fund R&D, but they already spend more on shareholder returns
by userby user[ad_1] Drug companies planning to raise prices on cancer drugs and other life-saving treatments are…
-
[ad_1] AstraZeneca PLC said Monday that its Imfinzi and Imjudo combinations have been recommended for…
-
[ad_1] Novartis AG said Monday that a trial to evaluate prostate-cancer drug Pluvicto met its…
-
STOCK MARKET
GSK Phase 3 trial for Jemperli endometrial cancer treatment met primary endpoint
by userby user[ad_1] GSK PLC said Friday that a Phase 3 trial for its Jemperli treatment for…
-
STOCK MARKET
Celcuity stock soars after hours on breakthrough therapy designation for cancer drug
by userby user[ad_1] Shares of Celcuity Inc. CELC, -0.75% were up 17% at $10.80 after hours as…
-
[ad_1] AstraZeneca PLC said Monday that its Enhertu drug has been recommended for approval in…